NIPH Clinical Trials Search

JAPANESE
UMIN ID: UMIN000028600

Registered date:10/08/2017

Evaluation of the effect of lactic acid bacteria on glucose metabolism in subjects with borderline diabetes

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedHealthy volunteers
Date of first enrollment2017/10/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Intake of granulated powder containing Pediococcus pentosaceus LP28 and dextrin (2 g/day) for 12 weeks. Intake of granulated powder of dextrin (2 g/day) for 12 weeks.

Outcome(s)

Primary Outcome12-week change in OGTT-2h
Secondary Outcome12-week changes in AUC, Cmax and Tmax of blood glucose and insulin in OGTT, insulinogenic index, FBS, HOMA-R, HbA1c, glycoalbumin, visceral fat area, body fat percentage, abdominal circumference

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum70years-old
GenderMale and Female
Include criteria
Exclude criteria1) HbA1c>=6.5% 2) Taking medicines or receiving health guidance for hypertension, diabetes, and/or hyperlipidemia 3) Taking drugs or functional food that may affect the trial 4) Participation in any clinical trial within 90 days of the commencement of the trial 5) In pregnancy or nursing a child 6) Judged as ineligible by clinical investigators

Related Information

Contact

public contact
Name Fumiko Higashikawa
Address Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, JAPAN Japan
Telephone 082-257-1533
E-mail fumiko@hiroshima-u.ac.jp
Affiliation Hiroshima University, Institute of Biomedical & Health Sciences Project Research Center for Clinical Trial and Preventive Medicine
scientific contact
Name Fumiko Higashikawa
Address Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, JAPAN Japan
Telephone 082-257-1533
E-mail fumiko@hiroshima-u.ac.jp
Affiliation Hiroshima University, Institute of Biomedical & Health Sciences Project Research Center for Clinical Trial and Preventive Medicine